ArticleFrontiers in immunology2026
Maternal rubella immunity gaps in the vaccine era: a seroepidemiological study of pregnant women in Jiangsu, China.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rubella elimination has substantially reduced virus circulation in China, but the changing pattern of immunity among women entering reproductive age remains unclear. We assessed the contemporary rubella immunity profile among pregnant women in Jiangsu Province. Methods: We conducted a cross-sectional serological study of 1,196 pregnant women in Jiangsu Province. Rubella-specific IgG antibodies were quantitatively measured. Seropositivity and antibody concentrations were compared across maternal age and birth cohorts. Restricted cubic spline (RCS) regression was used to assess nonlinear associations between age and immunity, and multivariable regression identified factors associated with seronegativity. Results: Overall rubella IgG seropositivity was 61.45%, with a geometric mean concentration of 24.21 IU/mL. Seropositivity increased from 37.77% among women aged ≤24 years to approximately 75% among women aged ≥30 years. Antibody concentrations showed a similar age-related gradient, with a nonlinear association between maternal age and rubella immunity. Younger birth cohorts consistently exhibited lower seropositivity and antibody concentrations, indicating a concentrated immunity gap among women entering reproductive age. Maternal age remained independently associated with rubella immunity, whereas gestational age was not. Conclusions: Despite sustained high RCV coverage and declining rubella transmission in China, substantial heterogeneity in maternal rubella immunity persists. Younger women and more recent birth cohorts may represent important susceptibility groups. Integrating maternal immunity surveillance with sustained childhood vaccination and preconception prevention strategies may help maintain rubella elimination and prevent congenital rubella syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.